Advancements in Allergen Immunotherapy for the Treatment of Atopic Dermatitis

Bei-Cyuan Guo,Kang-Hsi Wu,Chun-Yu Chen,Wen-Ya Lin,Yu-Jun Chang,Mao-Jen Lin,Han-Ping Wu
DOI: https://doi.org/10.3390/ijms25021316
IF: 5.6
2024-01-22
International Journal of Molecular Sciences
Abstract:Atopic dermatitis (AD) is a chronic inflammatory skin condition that affects individuals of all age groups, manifesting as a spectrum of symptoms varying from mild to severe. Allergen immunotherapy (AIT) involves the administration of allergen extracts and has emerged as a potential treatment strategy for modifying immune responses. Its pathogenesis involves epidermal barrier dysfunction, microbiome imbalance, immune dysregulation, and environmental factors. Existing treatment strategies encompass topical steroids to systemic agents, while AIT is under investigation as a potential immune-modifying alternative. Several studies have shown reductions in the severity scoring of atopic dermatitis (SCORAD) scores, daily rescue medication use, and visual analog scale (VAS) scores following AIT. Biomarker changes include increased IgG4 levels and decreased eosinophil counts. This review provides valuable insights for future research and clinical practice, exploring AIT as a viable option for the management of AD.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the application and effect of allergen immunotherapy (AIT) in the treatment of atopic dermatitis (AD). Specifically, the paper aims to evaluate the effectiveness of AIT in reducing the severity of AD symptoms, decreasing the use of daily rescue medications, and improving the quality of life of patients, and to explore the impact of AIT on AD - related biomarkers. In addition, the paper also discusses the potential value of AIT in clinical practice and future research directions. ### Overview of the Main Content of the Paper 1. **Introduction**: - Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects people of all ages, with symptoms ranging from mild to severe. - Allergen immunotherapy (AIT), which modulates the immune response by administering allergen extracts, is considered a potential treatment strategy. - Existing treatment methods include topical corticosteroids and systemic medications, and AIT is being studied as an immunomodulatory alternative therapy. 2. **Overview of AD**: - **Epidemiology**: The prevalence of AD is relatively high in children and also accounts for a certain proportion in adults. Globally, the prevalence of AD is approximately 20% in children and approximately 2 - 5% in adults. - **Pathogenesis**: The pathogenesis of AD involves epidermal barrier dysfunction, microbiota imbalance, immune dysregulation, and environmental factors. - **Clinical manifestations**: The main features of AD include pruritus, dry skin, lichenification, a disease course affected by emotional and environmental factors, involvement of flexural areas, and early - onset. 3. **Overview of AIT**: - **Mechanism**: AIT achieves immunomodulatory effects by changing the Th2 immune response, increasing the Th1 immune response, generating regulatory T cells (Treg), reducing allergen - specific IgE antibody levels, and increasing IgG4 levels. - **Administration methods**: AIT is mainly carried out by subcutaneous injection (SCIT) or sublingual administration (SLIT). Treatment is divided into a dose - escalation phase and a maintenance phase. - **Efficacy**: AIT has shown significant clinical efficacy in the treatment of allergic rhinitis, asthma, and allergic conjunctivitis. 4. **Application of AIT in the Treatment of AD**: - **Recent clinical research results**: Multiple clinical studies have shown that AIT has a significant effect in reducing the SCORAD score, the use of daily rescue medications, and the visual analog scale (VAS) of AD. Changes in biomarkers include an increase in IgG4 levels and a decrease in eosinophil counts. - **Summary**: The paper summarizes the data from 10 clinical studies, all of which indicate the safety and effectiveness of AIT in the treatment of AD. ### Conclusion This paper provides evidence of the effectiveness and safety of AIT in the treatment of AD by reviewing existing clinical studies and offers valuable insights for future research and clinical practice. The paper emphasizes the importance of AIT as a potentially viable option for AD management.